Cerus (CERS) Change in Accured Expenses (2010 - 2026)
Cerus (CERS) posted Change in Accured Expenses of -$1.9 million for Q2 2026, up 74.37% sequentially from -$7.5 million in Q1 2026, and down 158.86% YoY from $3.3 million in Q2 2025.
Cerus (CERS) Change in Accured Expenses (2010 - 2026) Analysis & Trends
Cerus has reported Change in Accured Expenses for 17 years, with the latest figure at -$1.9 million in Q2 2026.
- Quarterly Change in Accured Expenses fell 158.86% year-over-year to -$1.9 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$6.0 million (down 259.88% YoY) and the FY2025 annual result came in at $4.3 million, up 294.49% from the prior year.
- Change in Accured Expenses rose to -$1.9 million in Q2 2026 per CERS's latest filing, from -$7.5 million in the prior quarter.
- Over five years, Change in Accured Expenses peaked at $5.9 million in Q4 2022 and troughed at -$8.3 million in Q1 2022.
- A 5-year average of -$984166.7 and a median of -$755500.0 in 2023 frame the typical range for Change in Accured Expenses.
- The sharpest annual moves came in 2022 and 2023: Change in Accured Expenses soared 828.08% in 2022, then tumbled 498.19% in 2023.
- Over 5 years, Change in Accured Expenses stood at $5.9 million in 2022, then tumbled by 112.25% to -$724000.0 in 2023, then surged by 471.27% to $2.7 million in 2024, then jumped by 56.58% to $4.2 million in 2025, then plunged by 145.85% to -$1.9 million in 2026.
- According to Business Quant data, Change in Accured Expenses over the past three periods registered -$1.9 million, -$7.5 million, and $4.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 298.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 123.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 234.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 123.70 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 112.90 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 19.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 43.01 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 4.80 Mn |
| 10 | Cerus | 560.58 Mn | 504.32 Mn | 29.53 Mn | -1.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.93 Mn |
| Jun 30, 2026 | -1.93 Mn |
| Mar 31, 2026 | -7.53 Mn |
| Mar 31, 2026 | -7.53 Mn |
| Dec 31, 2025 | 4.21 Mn |
| Dec 31, 2025 | 4.21 Mn |
| Sep 30, 2025 | -787,000.00 |
| Sep 30, 2025 | -787,000.00 |
| Jun 30, 2025 | 3.28 Mn |
| Jun 30, 2025 | 3.28 Mn |
| Mar 31, 2025 | -2.43 Mn |
| Mar 31, 2025 | -2.43 Mn |
| Dec 31, 2024 | 2.69 Mn |
| Dec 31, 2024 | 2.69 Mn |
| Sep 30, 2024 | 235,000.00 |
| Sep 30, 2024 | 235,000.00 |
| Jun 30, 2024 | -1.53 Mn |
| Jun 30, 2024 | -1.53 Mn |
| Mar 31, 2024 | -3.59 Mn |
| Mar 31, 2024 | -3.59 Mn |